Type 1 diabetes: Lessons for other autoimmune diseases?

Journal of Autoimmunity

Volumn 31, Issue 3, 2008, Pages 306-310

  Harrison, Leonard C ^a   Honeyman, Margo C ^a   Morahan, Grant ^b   Wentworth, John M ^a   Elkassaby, Shirley ^a   Colman, Peter G ^a   Fourlanos, Spiros ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Autoimmune; Environment; Genes; Prevention; Type 1 diabetes

Indexed keywords

INSULIN; VITAMIN D;

ARTICLE; AUTOIMMUNE DISEASE; CLINICAL TRIAL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION;

ANIMALS; AUTOIMMUNE DISEASES; DIABETES MELLITUS, TYPE 1; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HUMANS; MICE; RISK FACTORS;

EID: 56349115784     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2008.04.026     Document Type: Article

References (40)

1. Bennett C.L., Christie J., Ramsdell F., Burnkkow M.E., Ferguson P.J., Whitesell L., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27 (2001) 20-21
2. Nerup J., Platz P., Andersen O.O., Christy M., Lyngsoe J., Poulsen J.E., et al. HL-A antigens and diabetes mellitus. Lancet 12 (1974) 864-866
3. Bottazzo G.F., Florin-Christensen A., and Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 2 (1974) 1279-1283
4. Gale E.A. The rise of childhood type 1 diabetes in the 20th century. Diabetes 51 (2002) 3353-3361
5. Haynes A., Bower C., Bulsara M.K., Jones T.W., and Davis2004 E.A. Continued increase in the incidence of childhood Type 1 diabetes in a population-based Australian sample. Diabetologia 47 (1985-2002) 866-870
6. Stene L.C., and Nafstad P. Relation between occurrence of type 1 diabetes and asthma. Lancet 357 (2001) 607
7. Bach J.F. The effect of infections on susceptibility to autoimmune and allergic diseases. New Engl J Med 347 (2002) 911-920
8. Todd J.A., Walker N.M., Cooper J.D., Smyth D.J., Downes K., Plagnol V., et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 39 (2007) 857-864
9. Gillespie K.M., Bain S.C., Barnett A.H., Bingley P.J., Christie M.R., Gill G.V., et al. The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet 364 (2004) 1699-1700
10. Hermann R., Knip M., Veijola R., Simell O., Laine A.P., Akerblom H.K., et al. Temporal changes in the frequencies of HLA genotypes in patients with Type 1 diabetes - indication of an increased environmental pressure?. Diabetologia 46 (2003) 420-425
11. Fourlanos S, Varney MD, Tait BD, Morahan G, Honeyman MC, Colman PG, et al. The rising incidence of type 1 diabetes is accounted for by cases with lower risk HLA genotypes. Diabetes Care (in press).
12. Fourlanos S., Narendran P., Byrnes G.B., Colman P.G., and Harrison L.C. Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 47 (2004) 1661-1667
13. Chaparro R.J., Konigshofer Y., Beilhack G.F., Shizuru J.A., McDevitt H.O., and Chien Y.-H. Nonobese diabetic mice express aspects of both type 1 and type 2 diabetes. Proc Natl Acad Sci U S A 103 (2006) 12475-12480
14. Pickup J.C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27 (2004) 813-823
15. Kolb H., and Mandrup-Poulsen T. An immune origin of type 2 diabetes?. Diabetologia 48 (2005) 1038-1050
16. Wellen K.E., and Hotamisligil G.S. Inflammation, stress, and diabetes. J Clin Invest 115 (2005) 1111-1119
17. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 444 (2006) 860-867
18. Gale E.A.M. A missing link in the hygiene hypothesis?. Diabetologia 45 (2002) 588-594
19. Bishop R.F., Cameron D.J., Veenstra A.A., and Barnes G.L. Diarrhoea and rotavirus infection associated with differing regimens for postnatal care of newborn infants. J Clin Microbiol 9 (1979) 525-529
20. Harrison L.C., and Honeyman M.C. Mucosa, not moocosa!. In: Robertson R.P. (Ed). Commentaries on perspectives in diabetes: 1988-1992 vol 3 (2006), USA: American Diabetes Association 158
21. Honeyman M.C., Coulson B.S., Stone N.L., Gellert S.A., Goldwater P.N., Steele C.E., et al. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes 49 (2000) 1319-1324
22. Strachan D.P. Hay fever, hygiene, and household size. BMJ 299 (1989) 1259-1260
23. Pozzilli P., Signore A., Williams A.J., and Beales P.E. NOD mouse colonies around the world - recent facts and figures. Immunol Today 14 (1993) 193-196
24. Funda D.P., Fundova P., and Harrison L.C. Microflora-dependency of selected diabetes-preventive diets: germ-free and ex-germ-free monocolonized NOD mice as models for studying environmental factors in type 1 diabetes. 13th International Congress of Immunology (2007), Rio de Janiero, Brazil 2007, p. MS11.14
25. Macpherson A.J., and Harris N.L. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 4 (2004) 478-485
26. Locke N.R., Stankovic S., Funda D.P., and Harrison L.C. TCR gamma delta intraepithelial lymphocytes are required for self-tolerance. J Immunol 176 (2006) 6553-6559
27. Narendran P., Mannering S.I., and Harrison L.C. Proinsulin - a pathogenic autoantigen in type 1 diabetes. Autoimmun Rev 2 (2003) 204-210
28. Shehadeh N., Shamir R., Berant M., and Etzioni A. Insulin in human milk and the prevention of type 1 diabetes. Pediatr Diabetes 2 (2001) 175-177
29. Odegaard A.O., and Pereira M.A. Trans fatty acids, insulin resistance, and type 2 diabetes. Nutr Rev 64 (2006) 364-372
30. Elliott S.S., Keim N.L., Stern J.S., Teff K., and Havel P.J. Fructose, weight gain and the insulin resistance syndrome. Am J Clin Nutr 76 (2002) 911-922
31. Yamagishi S., Ueda S., and Okuda S. Food-derived advanced glycation end products (AGEs): a novel therapeutic target for various disorders. Curr Pharm Des 13 (2007) 2832-2836
32. Özcan U., Cao Q., Yilmaz E., Lee A.H., Iwakoshi N.N., Özdelen E., et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306 (2004) 457-461
33. Hypponen E., Laara E., Reunanen A., Jarvelin M.R., and Virtanen S.M. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 362 (2001) 1389-1400
34. Holick M.F. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79 (2004) 362-371
35. Ascherio A., and Munger K. Epidemiology of multiple sclerosis: from risk factors to prevention. Semin Neurol 28 (2008) 17-28
36. The Eurodiab Substudy 2 Study Group. Vitamin D supplement in early childhood and risk for type 1 (insulin-dependent) diabetes mellitus. Diabetologia 42 (1999) 51-54
37. Stene L.C., Ulriksen J., Magnus P., and Joner G. Use of cod liver oil during pregnancy associated with lower risk of type 1 diabetes in the offspring. Diabetologia 43 (2000) 1093-1098
38. Harrison L.C. The prevention of autoimmune disease: type 1 diabetes as a paradigm. In: Rose N., and Mackay I. (Eds). The autoimmune diseases. 4th ed. vol. 75 (2006), Elsevier, London 1045-1062
39. Harrison L.C. Vaccination against self to prevent autoimmune disease: the type 1 diabetes model. Immunol Cell Biol 89 (2008) 139-145
40. Skyler J.S., Krischer J.P., Wolfsdorf J., Cowie C., Palmer J.P., Greenbaum C., et al. Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial - Type 1. Diabetes Care 28 (2005) 1068-1076